Mechanistic description
Aberrant MAP6 function may contribute to tau-independent cytoskeletal defects in neurodegeneration, and stabilizing MAP6-microtubule interactions pharmacologically could compensate for Tau pathology
Prediction: Small molecules enhancing MAP6-microtubule binding will ameliorate cytoskeletal defects in tau knockout neurons and improve neuronal survival in amyloid toxicity models
Mechanism / pathway
- MAP6
- neurodegeneration
Evidence for (5)
Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories.
Dynamic Palmitoylation Targets MAP6 to the Axon to Promote Microtubule Stabilization during Neuronal Polarization.
STOP proteins.
A cytoskeleton-membrane interaction conserved in fast-spiking neurons controls movement, emotion, and memory.
STOP proteins.
Evidence against (2)
Tau/MAP6 antagonism is shown in neuronal development models, but this does not establish that the same balance drives adult neurodegeneration progression or treatment response.
A microtubule-stabilizing peptide strategy failed to show clinical benefit in progressive supranuclear palsy, cautioning against simple cytoskeletal-stabilization translation in tauopathy.
Evidence matrix
Supporting
- Aberrant MAP6 function may contribute to tau-independent cytoskeletal defects in neurodegeneration, and stabilizing MAP6-microtubule interactions pharmacologically could compensate for Tau pathology
- Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories. PMID:34025352 · 2021 · Front Mol Neurosci
- Dynamic Palmitoylation Targets MAP6 to the Axon to Promote Microtubule Stabilization during Neuronal Polarization. PMID:28521134 · 2017 · Neuron
- STOP proteins. PMID:15218867 · 1999 · Cell Struct Funct
- A cytoskeleton-membrane interaction conserved in fast-spiking neurons controls movement, emotion, and memory. PMID:37833406 · 2023 · Mol Psychiatry
- STOP proteins. PMID:14567673 · 2003 · Biochemistry
Contradicting
- Tau/MAP6 antagonism is shown in neuronal development models, but this does not establish that the same balance drives adult neurodegeneration progression or treatment response. PMID:39257379 · 2024 · J Cell Sci
- A microtubule-stabilizing peptide strategy failed to show clinical benefit in progressive supranuclear palsy, cautioning against simple cytoskeletal-stabilization translation in tauopathy. PMID:24873720 · 2014 · Lancet Neurol
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). MAP6-mediated microtubule stabilization as therapeutic target. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-f3eff15058ab
@misc{scidex_hypothesis_hf3eff15,
title = {MAP6-mediated microtubule stabilization as therapeutic target},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-f3eff15058ab},
note = {SciDEX artifact hypothesis:h-f3eff15058ab}
}